Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 4752

BillFederalHouseIn Committee
Reducing Hereditary Cancer Act
About This Bill
Committee
Latest Action · July 23, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced
July 23, 2025
Cosponsors (34)
26D 8R
View PDF ↗
SummaryFull TextCommentsAnnotations

Full Text

Highlight any text to annotate
119th (2025–2027)
H.R. 4752
Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

https://www.congress.gov/119/bills/hr4752/BILLS-119hr4752ih.htm

https://www.congress.gov/119/bills/hr4752/BILLS-119hr4752ih.htm

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.